Walgreens Boots Alliance (NASDAQ:WBA) Releases FY 2025 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 1.400-1.800 for the period, compared to the consensus estimate of 1.750. The company issued revenue guidance of $147.0 billion-$151.0 billion, compared to the consensus revenue estimate of $147.3 billion.

Walgreens Boots Alliance Stock Performance

Walgreens Boots Alliance stock opened at $9.00 on Tuesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65. The company has a market capitalization of $7.77 billion, a PE ratio of -1.34, a P/E/G ratio of 1.04 and a beta of 0.70. The company has a 50 day moving average price of $9.41 and a 200-day moving average price of $13.31. Walgreens Boots Alliance has a fifty-two week low of $8.22 and a fifty-two week high of $27.05.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on WBA. UBS Group dropped their price objective on Walgreens Boots Alliance from $17.00 to $12.00 and set a neutral rating on the stock in a research report on Wednesday, July 3rd. TD Cowen cut their price objective on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a buy rating on the stock in a research report on Thursday, September 12th. Morgan Stanley decreased their target price on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an underweight rating for the company in a research report on Friday. Bank of America cut their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an underperform rating on the stock in a report on Wednesday, September 4th. Finally, Truist Financial decreased their price objective on Walgreens Boots Alliance from $13.00 to $10.00 and set a hold rating for the company in a report on Monday, October 7th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, Walgreens Boots Alliance presently has an average rating of Hold and an average target price of $13.46.

Read Our Latest Stock Report on Walgreens Boots Alliance

Walgreens Boots Alliance Company Profile

(Get Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Read More

Earnings History and Estimates for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.